Liver Cancer Clinical Trials

A listing of Liver Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 708 clinical trials
None
A Phase II Study of Tegafur/Uracil (UFUR )Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC)

Primary objective: To evaluate the overall response rate of tegafur/uracil (UFUR®) and thalidomide in the treatment of advanced or metastatic hepatocellular carcinoma. Secondary objectives: 1. To determine the disease stabilization rate; 2. To assess the progression-free survival and overall survival; 3. To establish the safety profile; 4. To evaluate the …

neutrophil count
thalidomide
arterial embolization
hepatoma
hepatitis
  • 32 views
  • 07 Nov, 2020
  • 1 location
None
Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma

The purpose of this study is to evaluate the clinical efficacy of thymopentin on the prevention of the recurrence and metastasis of small HCC after resection.

cancer
metastasis
  • 5 views
  • 07 Nov, 2020
  • 1 location
None
Intravascular Ultrasound for Hepatocellular Carcinoma Staging

To diagnose hepatocellular carcinoma (HCC) and to determine the extent of the disease, a triphasic CT scan or a magnetic resonance imaging are required. The characterization of hepatic nodules is more difficult when the HCC lesions have a diameter of less than 2 cm. Since accuracy in the assessment of …

ct scan
liver transplant
  • 10 views
  • 07 Nov, 2020
  • 1 location
None
Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using TACE With Antiangiogenesis

The purpose of this study is to investigate safety and potential therapeutic benefits for patients with hepatocellular carcinoma by transcatheter chemoembolization with the recombinant endostatin (commercially available in China)which is also administrated via the hepatic artery. The hypothesis of this protocol is that TACE with antiangiogenic treatment may inhibit the …

transcatheter arterial chemoembolisation
chemoembolization
measurable disease
TACE
local therapy
  • 2 views
  • 07 Nov, 2020
  • 1 location
None
Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria

The purpose of this study is to evaluate the influence of sirolimus on outcome after OLT for HCC exceeding Milan criteria.

vascular invasion
  • 1 views
  • 07 Nov, 2020
  • 1 location
None
Combi-elastography Assessment of HCC Recurrence After Thermal Ablation Multi-center Study

Combined F index, A index,ATT index and spleen stiffness to predict tumor recurrence in different liver settings after thermal ablation of HCC.

  • 0 views
  • 02 Feb, 2021
  • 1 location
None
Netrin-1 & Hepatocellular Carcinoma HCC

Netrin-1 is a dependence receptor ligand participating in the pathology of several cancer types. It is up-regulated in chronic liver diseases, cirrhosis and HCC. We hypothesize that netrin-1 may play a detrimental role in HCC. The goal of this project is to characterize netrin-1 signals in HCC samples with ad …

  • 0 views
  • 03 Mar, 2021
  • 1 location
None
Transarterial Embolization Alone Versus Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma

Developed in Japan in the 1980s, TACE became the most frequent treatment for unresectable hepatocellular carcinoma (HCC) in patients with preserved hepatic function after 2002, when two radiochemotherapies (RCTs) showed survival benefits for HCC patients who underwent conventional Lipiodol-based TACE (cTACE). Nowadays, nearly half of HCC patients undergo this procedure …

  • 0 views
  • 25 Mar, 2021
  • 1 location
None
Atezolizumab Plus Bevacizumab With HCC and HBV Infection

This is a single-arm clinical trial. The main objective is to determine the efficacy of atezolizumab+bevacizumab therapy in patients with advanced hepatocellular carcinoma and with chronic hepatitis B virus infection. All eligible patients will receive atezolizumab + bevacizumab therapy.

  • 0 views
  • 04 Apr, 2021
  • 8 locations
None
TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma

This study is a prospective phase II, single arm mono-institutional study conducted in Queen Mary Hospital (Hong Kong) assessing the efficacy and safety of the sequential administration of trans-arterial chemo-embolization (TACE) and stereotactic body radiotherapy (SBRT) with immune checkpoint inhibitors in unresectable hepatocellular carcinoma (HCC) patients.

  • 0 views
  • 11 Aug, 2021
  • 1 location